Page last updated: 2024-08-23

fosinopril and Polycystic Kidney, Autosomal Dominant

fosinopril has been researched along with Polycystic Kidney, Autosomal Dominant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berthier, C; Ferrari, P; Frey, FJ; Kappeler, A; Lods, N; Marti, HP; Vogt, B	1

Trials

1 trial(s) available for fosinopril and Polycystic Kidney, Autosomal Dominant

Article	Year
Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis. Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:11 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Case-Control Studies; Chronic Disease; Cross-Over Studies; Drug Therapy, Combination; Female; Fosinopril; Glomerulonephritis; Humans; Irbesartan; Male; Matrix Metalloproteinases; Middle Aged; Polycystic Kidney, Autosomal Dominant; Prospective Studies; Tetrazoles	2003

Article

Year

Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis.

Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:11

Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Case-Control Studies; Chronic Disease; Cross-Over Studies; Drug Therapy, Combination; Female; Fosinopril; Glomerulonephritis; Humans; Irbesartan; Male; Matrix Metalloproteinases; Middle Aged; Polycystic Kidney, Autosomal Dominant; Prospective Studies; Tetrazoles

2003